Search - tctmd.com

Displaying 21 - 40 of 58

Sort: Relevancy | Date

Presentation TVT 2019

Transfemoral Access for TAVR Made 'Simple' — Tips and Tricks to Optimize Outcomes

Presenter: Michael Rinaldi

June 13, 2019

Presentation TVT 2019

Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

Presenter: Torsten Vahl

June 13, 2019

Presentation TVT 2019

30-Day Outcomes From an Early Feasibility Study to Assess the Safety and Effectiveness of a Novel Transfemoral TAVR System for the Treatment of Patients With Symptomatic Severe Aortic Regurgitation (AR)

Presenter: Vinod Thourani

June 13, 2019

News Conference News TVT 2017

Merits of Minimalist TAVR: Patient Satisfaction and a Better Bottom Line

Michael O'Riordan

June 20, 2017

Presentation TVT 2017

Potential Barriers to Adopting a Minimalist Transfemoral TAVR Pathway: Emerging Solutions and Future Directions (3M Trial Updates)

Presenter: Axel Linke, Bernard Prendergast, David A. Wood

June 16, 2017

Presentation TVT 2017

Transfemoral Aortic Valve Replacement With a SAPIEN-3 Heart Valve in a Patient With Severe Scoliosis: A Roller Coaster Ride

Presenter: Albert Markus Kasel, Thomas Walther, Etienne Couture, MD

June 15, 2017

News Conference News TVT 2016

Teenage TAVR: Should Practice Forge on While Guidelines Grow Up?

Michael O'Riordan

June 20, 2016

News Conference News TVT 2016

What TAVR Needs Next . . . and What It’s Getting

Shelley Wood

June 17, 2016

Presentation TVT 2016

Be Prepared! The Management of Vascular Complications After Transfemoral TAVR

Presenter: James M. McCabe

June 16, 2016

Presentation TVT 2016

Step-by-Step: Vascular Screening, Transfemoral Access Techniques, and Percutaneous Closure After TAVR

Presenter: Jonathon M. White

June 16, 2016

News Conference News TVT 2016

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

Michael O'Riordan

June 16, 2016

Presentation TVT 2015

New Transfemoral Access Closure Devices

Presenter: Eberhard Grube

June 05, 2015

Presentation TVT 2015

Avoiding and Managing Transfemoral Vascular Complications

Presenter: Augusto D. Pichard

June 05, 2015

Presentation TVT 2015

An Interventionalists Perspective: Will the HEART TEAM Change With a Default Transfemoral TAVR Strategy for Most Patients?

Presenter: Nicolo Piazza

June 04, 2015

Presentation TVT 2015

A Surgeons Perspective: Will the IMPLANTING TEAM Change for Intermediate- and Low-Risk Transfemoral TAVR Patients?

Presenter: Francesco Maisano

June 04, 2015

Presentation TVT 2015

The North American 3M TAVR Study: Evaluating the Efficacy, Feasibility, and Safety of Next-Day Discharge Home in Patients Undergoing Elective Transfemoral TAVR

Presenter: David A. Wood

June 04, 2015

Presentation TVT 2015

Direct Aortic vs Subclavian-Axillary TAVR: Lessons From the CoreValve Pivotal Trial

Presenter: Raj Makkar, Mathew Williams, Thomas G. Gleason

June 04, 2015

Presentation TVT 2015

Transapical vs Direct Aortic TAVR: Lessons From the PARTNER Trial

Presenter: Raj Makkar, Mathew Williams, Vasilis Babaliaros

June 04, 2015

Presentation TVT 2015

Transcaval TAVR: Technique, Rationale, and Complications

Presenter: Raj Makkar, Mathew Williams, Adam B. Greenbaum

June 04, 2015

Presentation TVT 2015

Subclavian-Axillary TAVR: Optimal Technique and Complication Management

Presenter: Raj Makkar, Mathew Williams, A. Pieter Kappetein

June 04, 2015

Advertisement

Transfemoral Access for TAVR Made 'Simple' — Tips and Tricks to Optimize Outcomes

Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

30-Day Outcomes From an Early Feasibility Study to Assess the Safety and Effectiveness of a Novel Transfemoral TAVR System for the Treatment of Patients With Symptomatic Severe Aortic Regurgitation (AR)

Merits of Minimalist TAVR: Patient Satisfaction and a Better Bottom Line

Potential Barriers to Adopting a Minimalist Transfemoral TAVR Pathway: Emerging Solutions and Future Directions (3M Trial Updates)

Transfemoral Aortic Valve Replacement With a SAPIEN-3 Heart Valve in a Patient With Severe Scoliosis: A Roller Coaster Ride

Teenage TAVR: Should Practice Forge on While Guidelines Grow Up?

What TAVR Needs Next . . . and What It’s Getting

Be Prepared! The Management of Vascular Complications After Transfemoral TAVR

Step-by-Step: Vascular Screening, Transfemoral Access Techniques, and Percutaneous Closure After TAVR

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

New Transfemoral Access Closure Devices

Avoiding and Managing Transfemoral Vascular Complications

An Interventionalists Perspective: Will the HEART TEAM Change With a Default Transfemoral TAVR Strategy for Most Patients?

A Surgeons Perspective: Will the IMPLANTING TEAM Change for Intermediate- and Low-Risk Transfemoral TAVR Patients?

The North American 3M TAVR Study: Evaluating the Efficacy, Feasibility, and Safety of Next-Day Discharge Home in Patients Undergoing Elective Transfemoral TAVR

Direct Aortic vs Subclavian-Axillary TAVR: Lessons From the CoreValve Pivotal Trial

Transapical vs Direct Aortic TAVR: Lessons From the PARTNER Trial

Transcaval TAVR: Technique, Rationale, and Complications

Subclavian-Axillary TAVR: Optimal Technique and Complication Management

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content